Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs REKVINA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS REKVINA LABS NOVARTIS/
REKVINA LABS
 
P/E (TTM) x 26.6 -180.8 - View Chart
P/BV x 3.3 6.7 49.0% View Chart
Dividend Yield % 4.6 0.0 -  

Financials

 NOVARTIS   REKVINA LABS
EQUITY SHARE DATA
    NOVARTIS
Mar-23
REKVINA LABS
Mar-18
NOVARTIS/
REKVINA LABS
5-Yr Chart
Click to enlarge
High Rs7636 13,752.3%   
Low Rs5545 11,080.0%   
Sales per share (Unadj.) Rs153.40-  
Earnings per share (Unadj.) Rs41.9-0.1 -31,554.3%  
Cash flow per share (Unadj.) Rs44.3-0.1 -33,404.3%  
Dividends per share (Unadj.) Rs47.500-  
Avg Dividend yield %7.20-  
Book value per share (Unadj.) Rs314.20.7 46,662.1%  
Shares outstanding (eoy) m24.696.03 409.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.30-  
Avg P/E ratio x15.7-39.9 -39.5%  
P/CF ratio (eoy) x14.9-39.9 -37.3%  
Price / Book Value ratio x2.17.8 26.8%  
Dividend payout %113.50-   
Avg Mkt Cap Rs m16,26232 51,142.3%   
No. of employees `000NANA-   
Total wages/salary Rs m3560-   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,7870-  
Other income Rs m5810 305,842.1%   
Total revenues Rs m4,3690 2,299,210.5%   
Gross profit Rs m651-1 -65,737.4%  
Depreciation Rs m610-   
Interest Rs m180-   
Profit before tax Rs m1,154-1 -144,225.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1200-   
Profit after tax Rs m1,034-1 -129,200.0%  
Gross profit margin %17.20- 
Effective tax rate %10.40-   
Net profit margin %27.30- 
BALANCE SHEET DATA
Current assets Rs m7,8616 138,390.8%   
Current liabilities Rs m2,6834 67,742.4%   
Net working cap to sales %136.70- 
Current ratio x2.91.4 204.3%  
Inventory Days Days1,2010- 
Debtors Days Days350- 
Net fixed assets Rs m12,6562 543,171.7%   
Share capital Rs m12330 409.4%   
"Free" reserves Rs m7,634-26 -29,269.9%   
Net worth Rs m7,7574 191,059.1%   
Long term debt Rs m00-   
Total assets Rs m20,5178 256,141.1%  
Interest coverage x66.90-  
Debt to equity ratio x00-  
Sales to assets ratio x0.20-   
Return on assets %5.1-10.0 -51.4%  
Return on equity %13.3-19.7 -67.8%  
Return on capital %15.1-19.6 -76.9%  
Exports to sales %2.10-  
Imports to sales %00-  
Exports (fob) Rs m80NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m800-   
Fx outflow Rs m9460-   
Net fx Rs m-8660-   
CASH FLOW
From Operations Rs m4480 -194,782.6%  
From Investments Rs m-1,533NA-  
From Financial Activity Rs m-305NA -84,666.7%  
Net Cashflow Rs m-1,3890 -1,068,692.3%  

Share Holding

Indian Promoters % 0.0 41.3 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 0.7 0.0 -  
FIIs % 0.2 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 58.7 49.9%  
Shareholders   43,128 2,440 1,767.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   ADANI ENTERPRISES    REDINGTON    MMTC    SIRCA PAINTS INDIA    


More on Novartis vs REKVINA LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Novartis vs REKVINA LABS Share Price Performance

Period Novartis REKVINA LABS S&P BSE HEALTHCARE
1-Day -0.22% 0.00% 1.18%
1-Month 7.46% 0.00% -0.75%
1-Year 81.59% 7.91% 61.82%
3-Year CAGR 23.12% -3.77% 18.16%
5-Year CAGR 8.47% -8.27% 19.79%

* Compound Annual Growth Rate

Here are more details on the Novartis share price and the REKVINA LABS share price.

Moving on to shareholding structures...

The promoters of Novartis hold a 70.7% stake in the company. In case of REKVINA LABS the stake stands at 41.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of REKVINA LABS.

Finally, a word on dividends...

In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.

REKVINA LABS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Novartis, and the dividend history of REKVINA LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.